Emran, A.A.; Nsengimana, J.; Punnia-Moorthy, G.; Schmitz, U.; Gallagher, S.J.; Newton-Bishop, J.; Tiffen, J.C.; Hersey, P.
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers 2020, 12, 2082.
https://doi.org/10.3390/cancers12082082
AMA Style
Emran AA, Nsengimana J, Punnia-Moorthy G, Schmitz U, Gallagher SJ, Newton-Bishop J, Tiffen JC, Hersey P.
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers. 2020; 12(8):2082.
https://doi.org/10.3390/cancers12082082
Chicago/Turabian Style
Emran, Abdullah Al, Jérémie Nsengimana, Gaya Punnia-Moorthy, Ulf Schmitz, Stuart J. Gallagher, Julia Newton-Bishop, Jessamy C. Tiffen, and Peter Hersey.
2020. "Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts" Cancers 12, no. 8: 2082.
https://doi.org/10.3390/cancers12082082
APA Style
Emran, A. A., Nsengimana, J., Punnia-Moorthy, G., Schmitz, U., Gallagher, S. J., Newton-Bishop, J., Tiffen, J. C., & Hersey, P.
(2020). Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers, 12(8), 2082.
https://doi.org/10.3390/cancers12082082